A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Clinical trial NCT05905458 · COMPLETED
Trial details
- NCT number
- NCT05905458
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2024-11-22
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.